Ranbaxy’s JVC adjudged Malaysian Pharmaceutical Company of the Year for 2012

13 Apr 2012 Evaluate

Ranbaxy Malaysia Sdn. Bhd., Malaysia, a joint venture company (JVC) of Ranbaxy Laboratories, has received the 2012 Frost & Sullivan Malaysia Excellence Award for being adjudged the Malaysian Pharmaceutical Company of the Year in the Generics Drug Category. The methodology and selection process involved a rigorous independent market research by Frost & Sullivian and evaluation by a distinguished panel of independent judges.

The 2012 Frost & Sullivan Malaysia Excellence Award was conferred to Ranbaxy Malaysia at a ceremony held in Kuala Lumpur on April 12, 2012.

Ranbaxy Malaysia Sdn Bhd (RMSB) is a joint venture company of Ranbaxy Laboratories, India and Malaysian shareholders. Established in 1984, RMSB is today one of the major generic companies in this market providing medicines in the Cardiovascular, CNS, Anti-infective, Gastroenterology and Anti-viral therapeutic segments.

Ranbaxy Laboratories, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×